Tag: NTD Treatment Market

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Neglected Tropical Disease Treatment Market Value Expansion And Long-Term Growth Outlook

The market dedicated to treating neglected tropical diseases has witnessed robust expansion lately. Projections indicate a rise from $3.57 billion in 2025 to $3.8 billion in 2026, reflecting a compound annual growth rate of 6.3%. Factors contributing to this upswing during the past period include the persistent presence of these diseases in tropical areas, the backing received from international health entities, the broadening scope of treatment initiatives funded by donors, the accessibility of affordable generic medications, and heightened public health consciousness campaigns.

The global market for treating neglected tropical diseases is poised for substantial expansion in the upcoming years, projecting a valuation of $4.79 billion by 2030, driven by a compound annual growth rate of 6.0%. This anticipated growth stems from amplified funding for eradication initiatives, a broader embrace of holistic disease management strategies, advancements in the creation of new antiparasitic medications, burgeoning collaborations between public and private sectors, and a heightened commitment to extending healthcare services to underserved, remote areas. Key developments shaping this market trajectory include a greater utilization of multi-drug treatment regimens, a significant push towards programs focused on the early identification of diseases, increased reliance on mass drug administration techniques, the scaling up of community-level treatment frameworks, and a strengthened focus on making treatments readily available.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp

Neglected Tropical Disease Treatment Market Growth Drivers: What Factors Are Accelerating Expansion?

The increasing incidence of infectious illnesses is anticipated to boost the market for neglected tropical disease treatments. Infectious diseases, caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, can spread between individuals directly or indirectly. This heightened occurrence of such infections is exacerbated by global travel, which facilitates swift cross-border transmission of pathogens. Treatments for neglected tropical diseases contribute to managing infectious diseases by offering focused interventions that curb and eradicate their spread, thereby enhancing public health, particularly in vulnerable populations, by lessening disease impact and averting lasting impairments. As an illustration, by February 2024, the UK Health Security Agency reported that tuberculosis cases in England climbed to 4,850 in 2023, a 10.7% rise from the 4,380 cases recorded in 2022, underscoring the influence of rising infectious disease rates on the neglected tropical disease treatment market.

The bolstering of healthcare infrastructure is foreseen to be a significant driver for the expansion of the neglected tropical disease treatment market. Healthcare infrastructure encompasses the essential components like medical facilities, equipment, organizational systems, and human resources necessary for providing populace medical attention. This development in healthcare infrastructure is fueled by population increase, as growing communities necessitate more hospitals, clinics, and medical centers to cater to escalating healthcare needs. Medical antibacterial curtains play a role in strengthening healthcare infrastructure by minimizing infection transmission, fostering safer environments for patients, and assisting hospitals in upholding superior sanitary practices. For example, in 2024, the American Hospital Association noted that the United States maintained a total of 6,120 hospitals, an increase from the 6,093 facilities present in 2022, demonstrating the growth in medical establishments that supports the neglected tropical disease treatment market.

Neglected Tropical Disease Treatment Market Segments: Where Are The Largest Growth Opportunities?

The neglected tropical disease treatment market covered in this report is segmented –

1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class

2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types

3) By Route of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides

2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins

3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides

4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments

Neglected Tropical Disease Treatment Market Trends: What Is Shaping Future Industry Growth?

The key players within the market for treating neglected tropical diseases are actively pursuing the creation of novel treatments, specifically all-oral, field-deployable medications, with the aim of making administration easier, enhancing safety, and broadening availability in areas with limited resources. These all-oral therapies, exemplified by treatments for human African trypanosomiasis, utilize oral small-molecule drugs administered over a brief period, thereby increasing treatment accessibility, decreasing hospital stays, and mitigating logistical hurdles when contrasted with conventional injectable medications. A case in point is Sanofi S.A., a global pharmaceutical firm headquartered in France, which launched Fexinidazole Winthrop in December 2023, an oral therapy co-developed with non-profit entities. Fexinidazole, a nitro-based small molecule, is designed as a successor to older treatment plans that necessitated intravenous administration or inpatient care. Its oral form, along with a straightforward dosage regimen and a good safety record, renders it appropriate for all phases of specific sleeping sickness varieties, thereby extending treatment options in distant regions. Moreover, Fexinidazole offers a more convenient alternative to established treatments like melarsoprol and eflornithine, which are administered by injection, demand intricate patient observation, and present greater toxicity or operational complexities.

Neglected Tropical Disease Treatment Market Major Participants And Competitive Dynamics

Major companies operating in the neglected tropical disease treatment market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, Eisai Co Ltd, Shionogi And Co Ltd, Dr Reddys Laboratories Ltd, Cipla Ltd, Gilead Sciences Inc, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Alvogen

Access The Complete Neglected Tropical Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report

Neglected Tropical Disease Treatment Market Global Footprint: Which Region Holds Market Leadership?

Asia-Pacificwas the largest region in the neglected tropical disease treatment market in 2025. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Neglected Tropical Disease Treatment Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The market for treating neglected tropical diseases has experienced robust growth recently. Projections indicate it will expand from $3.57 billion in 2025 to $3.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. This historical expansion is attributable to factors such as persistent disease prevalence in tropical areas, backing from worldwide health organizations, the broadening of donor-supported treatment initiatives, the accessibility of generic medicines, and intensified public health awareness campaigns.

The neglected tropical disease treatment market is projected to experience robust expansion over the coming years, with its size expected to reach $4.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This anticipated growth can be attributed to several factors, including increased investments in eradication programs, the rising adoption of integrated disease management approaches, the expansion of novel antiparasitic drug development, the proliferation of public-private partnerships, and a heightened focus on improving healthcare access in remote regions. Significant trends during the forecast period are set to include the wider deployment of combination drug therapies, an increasing emphasis on early disease detection programs, the growing utilization of mass drug administration strategies, the broadening of community-based treatment models, and an enhanced focus on ensuring treatment accessibility.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp

Which Significant Factors Are Encouraging Growth In The Neglected Tropical Disease Treatment Market?

An increase in infectious disease cases is projected to propel the expansion of the neglected tropical disease treatment market in the future. These conditions are caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals either directly or indirectly. The growing incidence of infectious diseases stems from more frequent travel, enabling pathogens to quickly disseminate across different regions. Treatment for neglected tropical diseases supports the fight against infectious diseases by offering specific therapies designed to manage and eradicate their proliferation. Such treatments enhance public health, particularly for susceptible populations, by diminishing the impact of diseases and averting lasting impairments. For example, data from the UK Health Security Agency, a UK-based government body, indicated in February 2024 that tuberculosis occurrences in England escalated to 4,850 in 2023, representing a 10.7% jump from 4,380 cases in 2022. Consequently, the increased occurrence of infectious diseases is fueling the development of the neglected tropical disease treatment market.

How Are Different Segment Groups Identified Within The Neglected Tropical Disease Treatment Market?

The neglected tropical disease treatment market covered in this report is segmented –

1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class

2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types

3) By Route of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides

2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins

3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides

4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments

Which Trends Are Shaping The Neglected Tropical Disease Treatment Market Landscape?

Leading firms within the negative pressure wound therapy (NPWT) sector are actively developing innovative portable and disposable NPWT devices to solidify their market standing. These compact, single-use medical instruments apply controlled suction to wounds, facilitating healing by extracting surplus fluids and fostering ideal conditions for tissue restoration, all while providing convenient mobility and removing the necessity for cumbersome, conventional setups. For example, Advanced Oxygen Therapy Inc., a US-based medical equipment manufacturer, introduced its NEXA Negative Pressure Wound Therapy (NPWT) system in June 2023. The NEXA NPWT system provides a distinctive and adaptable platform, merging the straightforwardness of disposable NPWT with the robust performance characteristics of conventional durable NPWT technology. This portable, quiet, and economical system is designed to deliver enhanced wound care efficacy at a reduced expense. AOTI’s NEXA and Topical Wound Oxygen (TWO2) therapy uniquely integrates higher-pressure oxygen delivery with non-contact cyclical compression and humidity, positioning it as a beneficial choice for the management and healing of chronic wounds.

Who Are The Key Market Participants In The Neglected Tropical Disease Treatment Market?

Major companies operating in the neglected tropical disease treatment market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, Eisai Co Ltd, Shionogi And Co Ltd, Dr Reddys Laboratories Ltd, Cipla Ltd, Gilead Sciences Inc, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Alvogen

Access The Complete Neglected Tropical Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report

Which Region Accounts For The Highest Share Of The Neglected Tropical Disease Treatment Market?

Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2025. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Neglected Tropical Disease Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24616&type=smp

Browse Through More Reports Similar to the Global Neglected Tropical Disease Treatment Market 2026, By The Business Research Company

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Pain Management Devices And Therapies Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Defibrillator Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Neglected Tropical Disease Treatment Market During The Forecast Period?

The size of the neglected tropical disease treatment market has witnessed significant growth over the past few years. This market is anticipated to expand from $3.57 billion in 2025 to $3.8 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this historical growth include the enduring prevalence of these diseases in tropical regions, robust support from global health organizations, the broadening scope of donor-funded treatment programs, the accessibility of generic therapeutics, and intensified public health awareness campaigns.

The neglected tropical disease treatment market size is projected to show robust expansion in the upcoming years, with an anticipated rise to $4.79 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is fueled by factors such as escalating investments in eradication programs, the increasing adoption of integrated disease management approaches, the broadening scope of novel antiparasitic drug development, the proliferation of public-private partnerships, and a greater concentration on healthcare access in remote regions. Significant trends anticipated over the forecast timeframe include the wider deployment of combination drug therapies, a heightened focus on early disease detection initiatives, the expanding utilization of mass drug administration strategies, the growth of community-based treatment models, and an intensified emphasis on treatment accessibility.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp

What Leading Drivers Are Supporting The Neglected Tropical Disease Treatment Market Expansion?

The expanding occurrence of infectious diseases is anticipated to propel the neglected tropical disease treatment market going forward. Infectious diseases are defined as ailments resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, capable of spreading from person to person either directly or indirectly. The increased prevalence of these diseases is linked to more extensive travel, which facilitates the swift dispersion of pathogens across borders. Neglected tropical disease treatment supports the management of infectious diseases by offering targeted therapies aimed at controlling and eradicating disease transmission. These therapeutic approaches improve public health outcomes, especially for vulnerable communities, by decreasing the disease load and preventing long-term disabilities. For example, in February 2024, the UK Health Security Agency, a UK-based government organization, reported that tuberculosis cases in England reached 4,850 in 2023, marking a 10.7% increase from 4,380 cases in 2022. Thus, the growing prevalence of infectious diseases is driving the growth of the neglected tropical disease treatment market.

How Are Segments Identified Within The Neglected Tropical Disease Treatment Market Segment Framework?

The neglected tropical disease treatment market covered in this report is segmented –

1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class

2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types

3) By Route of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides

2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins

3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides

4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments

What Emerging Trends Are Seen In The Neglected Tropical Disease Treatment Market?

Major companies operating in the neglected tropical disease treatment market are concentrating on developing innovative solutions, such as all-oral, field-deployable therapeutics, to simplify administration, improve safety, and expand access in low-resource settings. All-oral therapeutics for diseases like human African trypanosomiasis involve small-molecule drugs administered orally over a short course, which helps improve treatment reach, reduce the need for hospitalization, and lower operational barriers compared with traditional injectable therapies. For instance, in December 2023, Sanofi S.A., a France-based multinational pharmaceutical company, introduced Fexinidazole Winthrop, an oral treatment developed in partnership with not-for-profit organizations. Fexinidazole is a nitro-containing small molecule designed to replace older regimens requiring intravenous delivery or hospitalization. Its oral formulation, simplified dosing schedule, and favorable safety profile make it suitable for use across both stages of certain forms of sleeping sickness, expanding treatment access in remote settings. Furthermore, Fexinidazole contrasts with traditional alternatives such as melarsoprol and eflornithine, which are injectable, require complex monitoring, and have higher toxicity or operational challenges.

Who Are The Companies Competing Within The Neglected Tropical Disease Treatment Market?

Major companies operating in the neglected tropical disease treatment market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, Eisai Co Ltd, Shionogi And Co Ltd, Dr Reddys Laboratories Ltd, Cipla Ltd, Gilead Sciences Inc, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Alvogen

Get The Full Neglected Tropical Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report

Where Is The Neglected Tropical Disease Treatment Market Most Concentrated Geographically?

Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2025. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Neglected Tropical Disease Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report

Browse Through More Reports Similar to the Global Neglected Tropical Disease Treatment Market 2026, By The Business Research Company

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Pain Management Devices And Therapies Market Report

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Defibrillator Devices And Equipment Market Report

https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Neglected Tropical Disease Treatment Market At The End Of The 2026–2030 Forecast Period?

The neglected tropical disease treatment market has witnessed substantial growth in recent years. It is projected to increase from $3.57 billion in 2025 to $3.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. This historic expansion can be ascribed to factors such as the enduring prevalence of these diseases in tropical areas, support from global health organizations, the expansion of donor-funded treatment programs, the availability of generic therapeutics, and heightened public health awareness initiatives.

The neglected tropical disease treatment market size is expected to show significant expansion over the next few years, with projections indicating it will reach $4.79 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.0%. This anticipated growth during the forecast period is primarily fueled by rising investments in eradication programs, the increasing adoption of integrated disease management strategies, the ongoing development of novel antiparasitic drugs, a rise in public-private partnerships, and a heightened focus on enhancing healthcare access in remote areas. Furthermore, key trends anticipated in this period include the increased deployment of combination drug therapies, a growing emphasis on early disease detection programs, expanded use of mass drug administration strategies, the development of community-based treatment models, and an intensified focus on treatment accessibility.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp

What Primary Drivers Are Shaping The Development Of The Neglected Tropical Disease Treatment Market?

The anticipated growth of the neglected tropical disease treatment market is linked to the increasing occurrence of infectious diseases. These illnesses originate from harmful microorganisms like bacteria, viruses, fungi, or parasites, capable of direct or indirect transmission between individuals. The heightened incidence of infectious diseases stems from greater travel, which expedites the cross-border dissemination of pathogens. Neglected tropical disease treatment supports the management of infectious diseases by offering specific therapies to curb and eradicate disease transmission. Such treatments enhance public health, particularly for susceptible populations, by alleviating disease impact and preventing enduring disabilities. For instance, the UK Health Security Agency reported in February 2024 that tuberculosis cases in England climbed to 4,850 in 2023, representing an increase of 10.7% from 4,380 cases in 2022. Consequently, the growing prevalence of infectious diseases is a key factor driving the expansion of the neglected tropical disease treatment market.

What Segment Types Make Up The Neglected Tropical Disease Treatment Market?

The neglected tropical disease treatment market covered in this report is segmented –

1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class

2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types

3) By Route of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides

2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins

3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides

4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments

What Key Developments And Trends Are Impacting The Neglected Tropical Disease Treatment Market?

Major companies engaged in the neglected tropical disease treatment market are dedicating efforts to developing innovative solutions, including all-oral, field-deployable therapeutics, with the goal of simplifying administration, improving safety, and expanding access in low-resource environments. All-oral therapeutics for conditions such as human African trypanosomiasis feature small-molecule drugs taken by mouth over a short duration, which helps enhance treatment reach, diminish the necessity for hospitalization, and lower operational barriers when compared with traditional injectable therapies. For example, in December 2023, Sanofi S.A., a France-based multinational pharmaceutical company, introduced Fexinidazole Winthrop, an oral treatment created in collaboration with not-for-profit organizations. Fexinidazole is a nitro-containing small molecule intended to replace older regimens that required intravenous administration or inpatient care. Its oral formulation, streamlined dosing schedule, and favorable safety profile make it suitable for application across both stages of certain forms of sleeping sickness, thereby increasing treatment accessibility in remote areas. Moreover, Fexinidazole stands in contrast to conventional alternatives like melarsoprol and eflornithine, which are injectable, necessitate complex monitoring, and carry higher toxicity or operational challenges.

Who Are The Key Players Driving Competition In The Neglected Tropical Disease Treatment Market?

Major companies operating in the neglected tropical disease treatment market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, Eisai Co Ltd, Shionogi And Co Ltd, Dr Reddys Laboratories Ltd, Cipla Ltd, Gilead Sciences Inc, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Alvogen

Read the full neglected tropical disease treatment market report here:

https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report

How Does The Neglected Tropical Disease Treatment Market Perform Across Major Global Regions?

Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2025. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Neglected Tropical Disease Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24616&type=smp

Browse Through More Reports Similar to the Global Neglected Tropical Disease Treatment Market 2026, By The Business Research Company

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Pain Management Devices And Therapies Global Market Report

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Defibrillator Devices And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model